Fundación Renal Iñigo Alvarez De Toledo Report issue

Foundation Phase 2 Phase 4

Organization Overview

First Clinical Trial
2006
NCT00369096
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Fundación Renal Iñigo Alvarez De Toledo

Active Ingredients

Drugs in Phase 4 Trials (1)

paricalcitol (zemplar) (1 trial)

Drugs in Phase 2 Trials (1)

enoxaparin (lovenox) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Albuminuria (Phase 4)

Inflammation (Phase 4)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Peritoneal Diseases (Phase 2)

Renal Insufficiency, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2